The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration
Open accessAbstract
Previous studies demonstrate that intrastriatal injections of fibrillar alpha-synuclein (α-syn) into mice induce Parkinson’s disease (PD)-like Lewy body (LB) pathology formed by aggregated α-syn in anatomically interconnected regions and significant nigrostriatal degeneration. The aim of the current study was to evaluate whether exogenous mouse α-syn pre-formed fibrils (PFF) injected into the striatum of rats would result in accumulation of LB-like intracellular inclusions and nigrostriatal degeneration. Sprague Dawley rats received unilateral intrastriatal injections of either non-fibrillized recombinant α-syn or PFF mouse α-syn in 1- or 2- sites and were euthanized at 30, 60 or 180 days post-injection (pi). Both non-fibrillized recombinant α-syn and PFF α-syn injections resulted in phosphorylated α-syn intraneuronal accumulations (i.e., diffuse Lewy neurite (LN)- and LB-like inclusions) with significantly greater accumulations following PFF injection. LB-like inclusions were observed in several areas that innervate the striatum, most prominently the frontal and insular cortices, the amygdala, and the substantia nigra pars compacta (SNpc). α-Syn accumulations co-localized with ubiquitin, p62, and were thioflavin-S-positive and proteinase-k resistant, suggesting PFF-induced pathology exhibits properties similar to human LBs. Although α-syn inclusions within the SNpc remained ipsilateral to striatal injection, we observed bilateral reductions in nigral dopamine neurons at the 180-day time point in both the 1- and 2-site PFF injection paradigms. PFF injected rats exhibited bilateral reductions in striatal dopaminergic innervation at 60 and 180 days and bilateral decreases in homovanillic acid; however, dopamine reduction was observed only in the striatum ipsilateral to PFF injection. Although the level of dopamine asymmetry in PFF injected rats at 180 days was insufficient to elicit motor deficits in amphetamine-induced rotations or forelimb use in the cylinder task, significant disruption of ultrasonic vocalizations was observed. Taken together, our findings demonstrate that α-syn PFF are sufficient to seed the pathological conversion and propagation of endogenous α-syn to induce a progressive, neurodegenerative model of α-synucleinopathy in rats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Self-citationGenome sequence of the Brown Norway rat yields insights into mammalian evolution
Rat Genome Sequencing Project Consortium, DNA sequencing: Baylor College of Medicine, Gibbs, R. A., Weinstock, G. M., Metzker, M. L., Muzny, D. M., Sodergren, E. J., Scherer, S., Scott, G., Steffen, D., et al. (2004) · Nature · doi:10.1038/nature02426 · Cited by 2,164
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Self-citationConway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
Alpha-synuclein and neurodegenerative diseases
Goedert, M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081564 · Cited by 1,408
The efficiency of systematic sampling in stereology—reconsidered
GUNDERSEN, H. J. G., JENSEN, E. B. V., KIÊU, K., & NIELSEN, J. (1999) · Journal of Microscopy · doi:10.1046/j.1365-2818.1999.00457.x · Cited by 1,317
Prion-like spreading of pathological α-synuclein in brain
Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Oikawa, T., Arai, T., Akiyama, H., Mann, D. M. A., & Hasegawa, M. (2013) · Brain · doi:10.1093/brain/awt037 · Cited by 867
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
Holmes, B. B., DeVos, S. L., Kfoury, N., Li, M., Jacks, R., Yanamandra, K., Ouidja, M. O., Brodsky, F. M., Marasa, J., Bagchi, D. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301440110 · Cited by 859
Hansen, C., Angot, E., Bergström, A.-L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43366 · Cited by 842
Volpicelli-Daley, L. A., Luk, K. C., & Lee, V. M.-Y. (2014) · Nature Protocols · doi:10.1038/nprot.2014.143 · Cited by 731
Self-citationα-Synuclein misfolding and Parkinson's disease
Breydo, L., Wu, J. W., & Uversky, V. N. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.002 · Cited by 657
Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., & Björklund, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02780.2002 · Cited by 649
Recasens, A., Dehay, B., Bové, J., Carballo‐Carbajal, I., Dovero, S., Pérez‐Villalba, A., Fernagut, P., Blesa, J., Parent, A., Perier, C., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24066 · Cited by 632
Differential Innervation of Direct- and Indirect-Pathway Striatal Projection Neurons
Wall, N. R., De La Parra, M., Callaway, E. M., & Kreitzer, A. C. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.014 · Cited by 489
Kiely, A. P., Asi, Y. T., Kara, E., Limousin, P., Ling, H., Lewis, P., Proukakis, C., Quinn, N., Lees, A. J., Hardy, J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1096-7 · Cited by 451
Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. A., Pal, A., Said, J., Marsico, G., Verbavatz, J.-M., Rodrigo-Angulo, M., et al. (2012) · Scientific Reports · doi:10.1038/srep00898 · Cited by 405
Species similarities and differences in pharmacokinetics.
Lin, J. H. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06742-x · Cited by 395
Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport
Freundt, E. C., Maynard, N., Clancy, E. K., Roy, S., Bousset, L., Sourigues, Y., Covert, M., Melki, R., Kirkegaard, K., & Brahic, M. (2012) · Annals of Neurology · doi:10.1002/ana.23747 · Cited by 372
Bancher, C., Braak, H., Fischer, P., & Jellinger, K. A. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90590-h · Cited by 318
Decressac, M., Mattsson, B., Lundblad, M., Weikop, P., & Björklund, A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.013 · Cited by 286
Tan, T. Z., Miow, Q. H., Huang, R. Y., Wong, M. K., Ye, J., Lau, J. A., Wu, M. C., Bin Abdul Hadi, L. H., Soong, R., Choolani, M., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201823 · Cited by 281
Nandhagopal, R., Kuramoto, L., Schulzer, M., Mak, E., Cragg, J., Lee, C. S., McKenzie, J., McCormick, S., Samii, A., Troiano, A., et al. (2009) · Brain · doi:10.1093/brain/awp209 · Cited by 259
Caudo‐rostral brain spreading of α‐synuclein through vagal connections
Ulusoy, A., Rusconi, R., Pérez‐Revuelta, B. I., Musgrove, R. E., Helwig, M., Winzen‐Reichert, B., & Monte, D. A. D. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302475 · Cited by 250
Behavioral tests for preclinical intervention assessment
Schallert, T. (2006) · NeuroRX · doi:10.1016/j.nurx.2006.08.001 · Cited by 242
Pasquier, D. A., Kemper, T. L., Forbes, W. B., & Morgane, P. J. (1977) · Brain Research Bulletin · doi:10.1016/0361-9230(77)90066-1 · Cited by 175
Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat
Kordower, J. H., Dodiya, H. B., Kordower, A. M., Terpstra, B., Paumier, K., Madhavan, L., Sortwell, C., Steece-Collier, K., & Collier, T. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.001 · Cited by 169
Self-citationKoprich, J. B., Johnston, T. H., Reyes, M. G., Sun, X., & Brotchie, J. M. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-43 · Cited by 168
α-Synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei
Braak, E., Sandmann-Keil, D., Rüb, U., Gai, W. P., de Vos, R. A. I., Jansen Steur, E. N. H., Arai, K., & Braak, H. (2001) · Acta Neuropathologica · doi:10.1007/s004010000247 · Cited by 162
Decressac, M., Mattsson, B., & Björklund, A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.02.012 · Cited by 158
Spieles-Engemann, A. L., Behbehani, M. M., Collier, T. J., Wohlgenant, S. L., Steece‐Collier, K., Paumier, K. L., Daley, B. F., Gombash, S. E., Madhavan, L., Mandybur, G. T., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.009 · Cited by 155
Self-citation[Alpha-synuclein in Parkinson's disease].
Oczkowska, A., Kozubski, W. P., & Dorszewska, J. (2014) · PubMed · Cited by 147
Precontact 50-kHz vocalizations in male rats during acquisition of sexual experience.
Biały, M., Rydz, M., & Kaczmarek, L. (2000) · Behavioral Neuroscience · doi:10.1037//0735-7044.114.5.983 · Cited by 146
Sacino, A. N., Brooks, M., McKinney, A. B., Thomas, M. A., Shaw, G., Golde, T. E., & Giasson, B. I. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2102-14.2014 · Cited by 141
Selective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions?
Double, K. L., Reyes, S., Werry, E. L., & Halliday, G. M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.001 · Cited by 126
Reduction of dopamine synaptic activity: Degradation of 50-khz ultrasonic vocalization in rats.
Ciucci, M. R., Ahrens, A. M., Ma, S. T., Kane, J. R., Windham, E. B., Woodlee, M. T., & Schallert, T. J. (2009) · Behavioral Neuroscience · doi:10.1037/a0014593 · Cited by 123
Kelńyi, G. (1967) · Acta Neuropathologica · doi:10.1007/bf00688089 · Cited by 117
Ciucci, M. R., Ma, S. T., Fox, C., Kane, J. R., Ramig, L. O., & Schallert, T. J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.02.020 · Cited by 116
Whishaw, I. Q., Metz, G. A. S., Kolb, B., & Pellis, S. M. (2001) · Developmental Psychobiology · doi:10.1002/dev.1041 · Cited by 110
Yonetani, M., Nonaka, T., Masuda, M., Inukai, Y., Oikawa, T., Hisanaga, S., & Hasegawa, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807482200 · Cited by 109
Lewy body pathology in fetal grafts
Chu, Y., & Kordower, J. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05229.x · Cited by 105
Müller, C. M., de Vos, R. A. I., Maurage, C., Thal, D. R., Tolnay, M., & Braak, H. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000171652.40083.15 · Cited by 104
Gombash, S. E., Manfredsson, F. P., Kemp, C. J., Kuhn, N. C., Fleming, S. M., Egan, A. E., Grant, L. M., Ciucci, M. R., MacKeigan, J. P., & Sortwell, C. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081426 · Cited by 101
Self-citationParkinson’s disease mouse models in translational research
Antony, P. M. A., Diederich, N. J., & Balling, R. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9330-x · Cited by 91
Differential Expression of Alpha-Synuclein in Hippocampal Neurons
Taguchi, K., Watanabe, Y., Tsujimura, A., Tatebe, H., Miyata, S., Tokuda, T., Mizuno, T., & Tanaka, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089327 · Cited by 69
Quality of Life Related to Swallowing in Parkinson’s Disease
Carneiro, D., Corio, M. D. G. W. D. S., Belo, L. R., Rabelo, A. R. D. M., Asano, A. G., & Lins, O. G. (2014) · Dysphagia · doi:10.1007/s00455-014-9548-3 · Cited by 69
Koprich, J. B., Chen, E., Kanaan, N. M., Campbell, N. G., Kordower, J. H., & Lipton, J. W. (2003) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(03)00091-6 · Cited by 64
Self-citationThe significance of motor (A)symmetry in Parkinson's disease
Marinus, J., & van Hilten, J. J. (2014) · Movement Disorders · doi:10.1002/mds.26107 · Cited by 63
Grant, L. M., Richter, F., Miller, J. E., White, S. A., Fox, C., Zhu, C., Chesselet, M., & Ciucci, M. R. (2014) · Behavioral Neuroscience · doi:10.1037/a0035965 · Cited by 54
Koprich, J. B., Campbell, N. G., & Lipton, J. W. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(03)00219-0 · Cited by 52
Self-citationEffect of aging on ultrasonic vocalizations and laryngeal sensorimotor neurons in rats
Basken, J. N., Connor, N. P., & Ciucci, M. R. (2012) · Experimental Brain Research · doi:10.1007/s00221-012-3096-6 · Cited by 51
Kanaan, N. M., Kordower, J. H., & Collier, T. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06307.x · Cited by 49
Self-citationCiucci, M. R., Ma, S. T., Kane, J. R., Ahrens, A. M., & Schallert, T. J. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.027 · Cited by 42
Dopamine D1 and D2 receptor antagonism effects on rat ultrasonic vocalizations
Ringel, L., Basken, J. N., Grant, L. M., & Ciucci, M. R. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.06.006 · Cited by 41
McNaught, K. S. P., JnoBaptiste, R., Jackson, T., & Jengelley, T. (2009) · Synapse · doi:10.1002/syn.20719 · Cited by 37
Gombash, S. E., Manfredsson, F. P., Mandel, R. J., Collier, T. J., Fischer, D. L., Kemp, C. J., Kuhn, N. C., Wohlgenant, S. L., Fleming, S. M., & Sortwell, C. E. (2014) · Gene Therapy · doi:10.1038/gt.2014.42 · Cited by 34
Self-citation
Cited by
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S., & Li-Hua, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01353-3 · Cited by 469
Guo, J. L., Narasimhan, S., Changolkar, L., He, Z., Stieber, A., Zhang, B., Gathagan, R. J., Iba, M., McBride, J. D., Trojanowski, J. Q., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160833 · Cited by 440
Self-citationModeling Parkinson’s Disease With the Alpha-Synuclein Protein
Gómez-Benito, M., Granado, N., García-Sanz, P., Michel, A., Dumoulin, M., & Moratalla, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00356 · Cited by 437
Progress towards therapies for disease modification in Parkinson's disease
Vijiaratnam, N., Simuni, T., Bandmann, O., Morris, H. R., & Foltynie, T. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00061-2 · Cited by 419
Rey, N. L., Steiner, J. A., Maroof, N., Luk, K. C., Madaj, Z., Trojanowski, J. Q., Lee, V. M.-Y., & Brundin, P. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160368 · Cited by 388
Self-citation
Metadata
- Authors
- Paumier, K. L., Luk, K. C., Manfredsson, F. P., Kanaan, N. M., Lipton, J. W., Collier, T. J., Steece-Collier, K., Kemp, C. J., Celano, S., Schulz, E., Sandoval, I. M., Fleming, S., Dirr, E., Polinski, N. K., Trojanowski, J. Q., Lee, V. M., & Sortwell, C. E.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 82
- Pages
- 185-199
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W658341232
- Cited by
- 392
- References
- 61
- FWCI
- 18.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.